JPMorgan Forecast Over 85% Upside for Two Biopharma Stocks Targeting Obesity and Chronic Conditions
JPMorgan Forecast Over 85% Upside for Two Biopharma Stocks Targeting Obesity and Chronic Conditions
The two biopharma firms have developed drug candidates to treat autoimmune and pulmonary diseases. They have demonstrated good safety profiles and efficacy in various stages of clinical trials.
Don't fix the issue, treat the symptom.
It's the American way.
That’s unchecked capitalism at work. There’s more money to be made by selling overpriced food that causes obesity through physical addiction than selling pharmaceuticals to reduce obesity. Fixing the issue would reduce profits in two industries.
The First Lady typically takes on a national advocacy campaign. Michelle Obama tried to challenge the food industry in their contribution to childhood obesity. After a long fight of many years, her campaign ended up focusing primarily on exercise. There’s a great documentary called Fed Up about her attempt.
They simply have too much power of influence due to toothless restrictions. We need Congress to create legislation to make industry more ethical. Corporations will not do it on their own.
One issue is that processed foods are made to be hyperpalatable. Pair that with agriculture subsidies that make meat and sugar (corn) cheaper than they should be and you have a recipe for an obesity crisis.
I believe reallocating those subsidies to healthier foods would be a great step towards fixing the issue, but healthy foods at the grocery store being cheap doesn't really compete with the convenience of fast food.